Cellbricks Therapeutics, a biotech startup focused on 3D-printing human tissue implants, has secured €10 million in funding. This includes a €7 million seed round, which will advance their proprietary biofabrication platform for vascularized human tissue. The company's ultimate goal is to develop the capabilities for manufacturing fully functional, implantable human organs.
